Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 9/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.49 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11211906 | 0.95 | MTNR1A (0.54) | MTNR1AMTNR1BCA1CA2CA12 | |
| SCHEMBL11232532 | 0.80 | MTNR1A (0.57) | MTNR1AMTNR1BCA1CA2CA12 | |
| SCHEMBL2205376 | 0.79 | EPHX2 (0.47) | MTNR1AMTNR1B | |
| SCHEMBL24263104 | 0.75 | MTNR1A (0.50) | MTNR1AMTNR1BCA1CA2CA12 | |
| SCHEMBL11222659 | 0.74 | MTNR1A (0.49) | MTNR1AMTNR1BCA1CA2CA12 | |
| SCHEMBL11275699 | 0.72 | MTNR1A (0.66) | MTNR1AMTNR1BCA1CA2CA12 | |
| SCHEMBL13787618 | 0.69 | TOP2A (0.37) | MTNR1AMTNR1B | |
| SCHEMBL5053493 | 0.69 | MTNR1A (0.64) | MTNR1AMTNR1BCA1CA2ACHE | |
| SCHEMBL5053490 | 0.69 | MTNR1A (0.64) | MTNR1AMTNR1BCA1CA2ACHE | |
| SCHEMBL16082811 | 0.69 | MTNR1A (0.52) | MTNR1AMTNR1BCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0013789-B1 | AMINO-SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H (OR 2H)-INDAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ELI LILLY AND COMPANY (US) | 1983-02-02 | — | — | EP | disclosed |
| US-4322540-A | PROLACTIN INHIBITOR | ELI LILLY AND COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4322430-A | Amino-substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles | ELI LILLY AND COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4276300-A | PROLACTIN INHIBITORS | ELI LILLY AND COMPANY (US) | 1981-06-30 | — | — | US | disclosed |
| EP-0013789-A1 | Amino-substituted 4,5,6,7-tetrahydro-1H (or 2H)-indazoles, their preparation and pharmaceutical compositions containing them | ELI LILLY AND COMPANY (US) | 1980-08-06 | — | — | EP | disclosed |